Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 184.4M | 36.6M | 8.8M | 12.4M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -20.6M | -101.4M | -114.8M | -104.4M |
| EBITDA | — | — | — | — |
| Net Income | -6.9M | -89.0M | -104.7M | -101.1M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 59M | 54M | 44M | 39M |
Stoke Therapeutics Inc. Income Statement — FAQ
Stoke Therapeutics Inc. (STOK) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STOK's income statement history?
The chart and table above show Stoke Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.